TUVQURTI
"TUVQURTI" is a word mark owned by Kite Pharma, Inc., filed at the USPTO on October 22, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 22, 2026
- Filed
- October 22, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50177079
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns TUVQURTI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Kite Pharma, Inc.
Foster City, United States
Representative
Cynthia Smuzynska
Gilead Sciences, Inc.
What the mark covers
The products and services TUVQURTI is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of cancer and tumors, and autoimmune diseases and disorders; Biological preparations for the treatment of cancer; Biologics in the nature of pharmaceutical preparations for the treatment of cancer and autoimmune diseases
What has happened so far
Steps recorded by the USPTO, newest first.
- New application office supplied data entered
- Application filing receipt mailed
- New application entered
About TUVQURTI
Who owns the trademark "TUVQURTI"?
The USPTO trademark "TUVQURTI" (application 50177079) is owned by Kite Pharma, Inc.
What is the status of "TUVQURTI"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull TUVQURTI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a168de-6da8-70dc-a115-8dd5eb217f9e
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a168de-6da8-70dc-a115-8dd5eb217f9e",
"object": "trademark",
"mark_text": "TUVQURTI",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50177079",
"filing_date": "2026-10-22",
"nice_classes": [
5
],
"owners": [
{
"name": "Kite Pharma, Inc.",
"entity_id": "ent_019ebb01-c91d-76c9-8a8c-012bbefadcab"
}
]
}